Sustainability | May 08, 2025
Granules India bags EcoVadis’ Gold Rating
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
The portfolio includes branded injectable cephalosporines for infectious diseases
Subscribe To Our Newsletter & Stay Updated
